Bioventus Inc. (BVS)

Bioventus Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 19, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Cap	890	499	690	333	162	863
Market Cap Growth	83.18%	-27.70%	107.09%	105.83%	-81.23%	-
Enterprise Value	1,143	771.26	994.83	710.98	603.79	1,233
Last Close Price	10.66	7.44	10.50	5.27	2.61	14.49
PE Ratio	26.45	22.55	-	-	-	-
Forward PE	13.47	9.79	20.00	21.82	17.17	21.50
PEG Ratio	1.28	-	-	-	-	2.07
PS Ratio	1.55	0.88	1.20	0.65	0.32	2.00
PB Ratio	3.82	2.71	4.67	1.92	0.50	1.88
P/TBV Ratio	3.91	2.79	4.58	1.90	0.49	1.44
P/FCF Ratio	8.85	6.92	18.27	41.77	-	91.11
P/OCF Ratio	8.65	6.69	17.80	21.73	-	37.53
EV/Sales Ratio	1.98	1.36	1.74	1.39	1.18	2.86
EV/EBITDA Ratio	14.13	7.64	28.95	-	-	26.28
EV/EBIT Ratio	18.97	14.29	-	-	-	102.27
EV/FCF Ratio	11.36	10.70	26.33	89.07	-	130.23
Debt / Equity Ratio	1.08	1.22	1.66	1.66	0.93	0.64
Debt / EBITDA Ratio	2.62	2.91	9.77	-	-	7.62
Debt / FCF Ratio	2.70	4.08	8.88	49.47	-	37.77
Net Debt / Equity Ratio	1.25	1.32	1.99	2.06	1.19	0.68
Net Debt / EBITDA Ratio	2.27	2.40	8.56	-14.69	-3.47	6.69
Net Debt / FCF Ratio	2.35	3.37	7.78	44.84	-25.83	33.13
Asset Turnover	0.86	0.80	0.75	0.47	0.39	0.50
Inventory Turnover	4.34	-	4.05	2.09	2.47	2.82
Quick Ratio	1.06	1.12	0.80	0.91	0.55	0.93
Current Ratio	1.69	1.70	1.31	1.53	0.90	1.45
Return on Equity (ROE)	14.93%	26.35%	-46.27%	-100.05%	-75.70%	6.21%
Return on Assets (ROA)	8.85%	8.11%	-1.78%	-7.49%	-9.85%	1.69%
Return on Invested Capital (ROIC)	12.04%	11.25%	-2.36%	-8.96%	-11.55%	2.20%
Return on Capital Employed (ROCE)	11.22%	10.37%	-2.64%	-9.59%	-15.82%	1.70%
Earnings Yield	3.20%	4.44%	-	-	-	-
FCF Yield	11.30%	14.45%	5.47%	2.39%	-	1.10%
Buyback Yield / Dilution	-7.22%	-6.77%	-3.03%	-2.05%	-35.00%	11.70%
Total Shareholder Return	-7.22%	-6.77%	-3.03%	-2.05%	-35.00%	11.70%

Updated May 6, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q